fdaheadlines.com
Cerus Corporation (NASDAQ:CERS) Announces Fourth Quarter and Full Year 2018 Financial Results - FDA Headlines
Cerus Corporation (NASDAQ:CERS) closed Thursday’s trading session at $6.48, almost two weeks after it released its 2018 financial results including news of a record fourth quarter. The company announced that its Q4 2018 product revenue was $16.5 million, just slightly higher than the $16.2 million that the company reported for the corresponding period in the …